Forbes November 14, 2022
Gabriel A. Silva

Pelin Wood Thorogood is a tech executive turned impact entrepreneur who co-founded Radicle Science in 2018, an AI-driven health technology benefit corporation (B-corp). She also serves as Executive Chair for Radicle Science. Ms. Thorogood was previously Chief Marketing Officer of WebSideStory, which was acquired by Adobe/Omniture in 2008, and CEO of Anametrix, acquired by Ensighten in 2015, an award-winning predictive analytics company. Her involvement and work in education and community has had a deep impact. Ms. Thorogood is co-founder and President of the Wholistic Research and Education Foundation, Trustee and Treasurer of the University of California San Diego Foundation, Executive Board member of the UC San Diego Basement start-up incubator, and co-chair of the UC San Diego Innovation and Entrepreneurship...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Trends
Cerevance raises $47m to fund Phase III trial for lead Parkinson’s therapy
Parexel strikes deal with Palantir for clinical trial AI
Risklick debuts new AI software that writes clinical trial protocols
“Intentional effort” needed from sponsors to achieve diversity in oncology clinical trials
It’s Time to Give Patients a Seat at the Table

Share This Article